Hikma Pharmaceutical | HIK - Ebitda

Prezzo Delle Azioni
1,442.50
Cambio Giornaliero
31.50 2.23%
Mensile
12.21%
Annuale
-28.02%
Q2 Previsione
1,384.20




Ebitda Cambiamento Data
Almirall EUR 114.07M 60.37M 2025-12
argenx SE USD 387.05M 99.02M 2025-09
AstraZeneca USD 5.67B 1.29B 2026-03
Autolus Therapeutics Ltd USD -70.08M 11.23M 2025-09
Bayer EUR 1.97B 457M 2025-12
Fresenius EUR 850M 22M 2025-09
Galapagos EUR 2.42M 161.13M 2025-09
Genmab DKK 186M 291M 2025-12
GlaxoSmithKline GBP 2.77B 1.65B 2026-03
GRIFOLS EUR 347.45M 210K 2025-12
Hikma Pharmaceutical USD 369M 84M 2024-12
Lonza CHF 1.01B 54M 2025-12
Merck EUR 1.44B 263M 2025-12
Orion EUR 130.4M 212.6M 2026-03
Recordati EUR 247.15M 421K 2025-12
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 3.31B 3.65B 2026-03
UCB EUR 1.6B 570M 2025-12